Search research articles
Contact Us
Filters
Showing results (11-20 of 106) with videos related to
Page
of 11
Sort By:
Anticancer Research
|
April 12, 2012
EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome
Yinan Liu, Andrew J Sanders, Lijian Zhang, et al.
Angiogenesis
|
September 18, 2010
The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis
Andrew J Sanders, Lin Ye, Malcolm D Mason, et al.
International Journal of Molecular Medicine
|
September 6, 2007
Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro
Andrew J Sanders, Christian Parr, Malcolm D Mason, et al.
Anticancer Research
|
March 16, 2016
Targeting of Receptor Activator of Nuclear Kappa B (RANK) in PC-3 Cells Increases Cell Proliferation and Matrix Adhesion In Vitro
Sioned Owen, Andrew J Sanders, Malcolm D Mason, et al.
International Journal of Oncology
|
January 20, 2016
Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro
Sioned Owen, Andrew J Sanders, Malcolm D Mason, et al.
Journal of Oncology
|
May 15, 2010
IL-17B Can Impact on Endothelial Cellular Traits Linked to Tumour Angiogenesis
Andrew J Sanders, Xiaoxia Guo, Malcolm D Mason, et al.
Experimental and Therapeutic Medicine
|
September 13, 2012
Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications
Wen G Jiang, Andrew J Sanders, Fiona Ruge, et al.
Anticancer Research
|
January 29, 2011
Prognostic value of the human antigen R (HuR) in human breast cancer: high level predicts a favourable prognosis
Zhu Yuan, Andrew J Sanders, Lin Ye, et al.
Journal of Experimental Therapeutics & Oncology
|
June 25, 2011
Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro
Zhicheng Ge, Andrew J Sanders, Lin Ye, et al.
Cancers
|
November 12, 2013
Association of Differentiation-Related Gene-1 (DRG1) with Breast Cancer Survival and in Vitro Impact of DRG1 Suppression
Ruqia Mehmood Baig, Andrew J Sanders, Mahmood Akhtar Kayani, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 106) with videos related to
Sort By:
Page
of 11
Anticancer Research
|
April 12, 2012
EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome
Yinan Liu, Andrew J Sanders, Lijian Zhang, et al.
Angiogenesis
|
September 18, 2010
The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis
Andrew J Sanders, Lin Ye, Malcolm D Mason, et al.
International Journal of Molecular Medicine
|
September 6, 2007
Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro
Andrew J Sanders, Christian Parr, Malcolm D Mason, et al.
Anticancer Research
|
March 16, 2016
Targeting of Receptor Activator of Nuclear Kappa B (RANK) in PC-3 Cells Increases Cell Proliferation and Matrix Adhesion In Vitro
Sioned Owen, Andrew J Sanders, Malcolm D Mason, et al.
International Journal of Oncology
|
January 20, 2016
Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro
Sioned Owen, Andrew J Sanders, Malcolm D Mason, et al.
Journal of Oncology
|
May 15, 2010
IL-17B Can Impact on Endothelial Cellular Traits Linked to Tumour Angiogenesis
Andrew J Sanders, Xiaoxia Guo, Malcolm D Mason, et al.
Experimental and Therapeutic Medicine
|
September 13, 2012
Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications
Wen G Jiang, Andrew J Sanders, Fiona Ruge, et al.
Anticancer Research
|
January 29, 2011
Prognostic value of the human antigen R (HuR) in human breast cancer: high level predicts a favourable prognosis
Zhu Yuan, Andrew J Sanders, Lin Ye, et al.
Journal of Experimental Therapeutics & Oncology
|
June 25, 2011
Expression of death decoy receptor-3 (DcR3) in human breast cancer and its functional effects on breast cancer cells in vitro
Zhicheng Ge, Andrew J Sanders, Lin Ye, et al.
Cancers
|
November 12, 2013
Association of Differentiation-Related Gene-1 (DRG1) with Breast Cancer Survival and in Vitro Impact of DRG1 Suppression
Ruqia Mehmood Baig, Andrew J Sanders, Mahmood Akhtar Kayani, et al.
Page
of 11